Skip to Content

WPI 62.5 (Bosentan Monohydrate 62.5 mg)

Pill with imprint WPI 62.5 is Orange, Round and has been identified as Bosentan Monohydrate 62.5 mg. It is supplied by Actavis Pharma, Inc..

Bosentan is used in the treatment of pulmonary hypertension and belongs to the drug class agents for pulmonary hypertension. Not for use in pregnancy. Bosentan 62.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 62.5

Bosentan Monohydrate

Imprint
WPI 62.5
Strength
62.5 mg
Color
Orange
Shape
Round
Availability
Prescription only
Drug Class
Agents for pulmonary hypertension
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
Manufacturer
Watson Pharma Private Limited
National Drug Code (NDC)
00591-2511

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.